Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

BACKGROUND The relationship between total cholesterol levels and dementia is unclear. OBJECTIVE To compare the natural history of change in total cholesterol across 26 years between men who did and did not develop dementia 3 years after the last measurement. DESIGN, SETTING, AND PARTICIPANTS In the Honolulu-Asia Aging Study, 1027 Japanese American men had total cholesterol levels assayed on 5 occasions between 1965 and 1993 and were screened for dementia on 2 occasions between 1991 and 1996. MAIN OUTCOME MEASURE The slope of 26-year change in serum total cholesterol levels was estimated by a repeated-measures analysis and was compared between men with incident dementia (n = 56) and those without dementia (n = 971) at the end of the follow-up period. RESULTS Cholesterol levels in men with dementia and, in particular, those with Alzheimer disease had declined at least 15 years before the diagnosis and remained lower than cholesterol levels in men without dementia throughout that period. The difference in slopes was robust to adjustment for potential confounding factors, including vascular risk factors, weight change, alcohol intake, and use of lipid-lowering agents. CONCLUSION A decline in serum total cholesterol levels may be associated with early stages in the development of dementia.

[1]  Linda Teri,et al.  6/Use of the Center for Epidemiological Studies-Depression Scale with Older Adults , 1986 .

[2]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[3]  T. Seeman,et al.  Does Inflammation or Undernutrition Explain the Low Cholesterol–Mortality Association in High‐Functioning Older Persons? MacArthur Studies of Successful Aging , 2003, Journal of the American Geriatrics Society.

[4]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[5]  D. Russell,et al.  Blood cholesterol screening , 1990, The Lancet.

[6]  R. Stewart,et al.  A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. , 2005, Archives of neurology.

[7]  D. Reed,et al.  Plasma Lipids and Lipoproteins in Elderly Japanese‐American Men , 1986, Journal of the American Geriatrics Society.

[8]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[10]  L. Ferrucci,et al.  Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons , 1997, Annals of Internal Medicine.

[11]  M. M. Mielke,et al.  High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.

[12]  Johanna Kuusisto,et al.  Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study , 1997, BMJ.

[13]  B. Winblad,et al.  Decline in Blood Pressure Over Time and Risk of Dementia: A Longitudinal Study From the Kungsholmen Project , 2004, Stroke.

[14]  Richard Mayeux,et al.  Relation of plasma lipids to Alzheimer disease and vascular dementia. , 2004, Archives of neurology.

[15]  E Lesaffre,et al.  Local influence in linear mixed models. , 1998, Biometrics.